Treatment of myelodysplastic syndrome, acute leukemia and chronic myelomonocytic leukemia with 5-azacytidine: Comparative results from a single centre

被引：0
|
作者：
Montalvao, A. [1 ]
机构：
[1] Unidade Local Saude Baixo Alentejo, Hematol, Beja, Portugal
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70352-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-305
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [31] Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome
    Tey, Amanda
    Shaw, Briony
    Cardamone, Luke
    Shepherd, Sam
    Paul, Eldho
    Rogers, Ben
    Shortt, Jake
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (02) : 181 - 189
  • [32] Glasdegib Hedgehog signaling inhibitor Treatment of myelodysplastic syndrome Treatment of chronic myelomonocytic leukemia Treatment of acute myeloid leukemia Treatment of myelofibrosis
    Gras, J.
    DRUGS OF THE FUTURE, 2017, 42 (05) : 265 - 274
  • [33] 5-AZACYTIDINE FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA: RESULTS IN 45 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
    Musto, P.
    Maurillo, L.
    Spagnoli, A.
    Genuardi, M.
    Lunghi, M.
    Di Renzo, N.
    Mele, G.
    Levis, A.
    D'Arco, A.
    Gozzini, A.
    Petrini, M.
    Mianulli, M.
    Sanpaolo, G.
    Santagostino, A.
    Pietrantuono, G.
    D'Auria, E.
    Ferrero, D.
    Gaidano, G.
    Ferrara, E.
    Santini, V.
    Leone, G.
    Bosi, A.
    Venditti, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 93 - 93
  • [34] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Andrea Kuendgen
    Gesine Bug
    Oliver G. Ottmann
    Detlef Haase
    Julie Schanz
    Barbara Hildebrandt
    Kathrin Nachtkamp
    Judith Neukirchen
    Ariane Dienst
    Rainer Haas
    Ulrich Germing
    Norbert Gattermann
    Clinical Epigenetics, 2011, 2 : 389 - 399
  • [35] Treatment of Myelodysplastic Syndrome Transforming into Acute Myelogenous Leukemia with Azacytidine: A Retrospective Study from Cancer Centre in Northern India
    P. Suresh
    A. Sharma
    D. Bhurani
    Indian Journal of Hematology and Blood Transfusion, 2010, 26 : 114 - 114
  • [36] Immunomodulatory effects of 5-azacytidine in acute myeloid leukemia
    Letsch, Anne
    Doering, Susanne
    Quass, Petra
    Pezzutto, Antonio
    Ochsenreither, Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Overcoming Resistance to 5-Azacytidine in Acute Myelogenous Leukemia
    Sripayap, Piyanuch
    Nagai, Tadashi
    Uesawa, Mitsuyo
    Kobayashi, Hiroyuki
    Tsukahara, Tomonori
    Ohmine, Ken
    Muroi, Kazuo
    Baley, Gary
    Ozawa, Keiya
    BLOOD, 2012, 120 (21)
  • [38] Treatment of Myelodysplastic Syndrome Transforming into Acute Myelogenous Leukemia with Azacytidine: A Retrospective Study from Cancer Centre in Northern India
    Suresh, P.
    Sharma, A.
    Bhurani, D.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2010, 26 (03) : 114 - 114
  • [39] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Kuendgen, Andrea
    Bug, Gesine
    Ottmann, Oliver G.
    Haase, Detlef
    Schanz, Julie
    Hildebrandt, Barbara
    Nachtkamp, Kathrin
    Neukirchen, Judith
    Dienst, Ariane
    Haas, Rainer
    Germing, Ulrich
    Gattermann, Norbert
    CLINICAL EPIGENETICS, 2011, 2 : 389 - 399
  • [40] 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
    A Czibere
    I Bruns
    N Kröger
    U Platzbecker
    J Lind
    F Zohren
    R Fenk
    U Germing
    T Schröder
    T Gräf
    R Haas
    G Kobbe
    Bone Marrow Transplantation, 2010, 45 : 872 - 876
12345